Zoledronic Acid May Be Better Than Risedronate for Paget's Disease
5th Sep 2005, 21:26 GMT
In randomized trials, a single infusion of zoledronic acid produced more rapid, more complete, and more sustained responses than did daily treatment with risedronate. (CME) Medscape Medical News Hien Nghiem,Laurie Barclay,Gary Vogin
Latest news from Medscape Internal Medicine Headlines:
- National Medical Association 2006 Annual Convention and Scientific Assembly
- Highlights of National Medical Association 2006 Annual Convention and Scientific Assembly
- PSA Screening May Not Be Warranted in Elderly Men With Limited Life Expectancy
- Weight Loss Improves Glucose Tolerance in Nonobese, Healthy Adults
- Depressed Men Have Lower Testosterone Levels
- Canadian Study Indicates BNP Test for Suspected Feart Failure is Cost-effective
- Multiple Sclerosis (MS) of the Spinal Cord
- A Survey of Neurologists on Bothersome Patient Behaviors
- Brand-Name Buying Drugs Fuels Boom in Overall Drug Spending
- The Middle Way: A Practical Approach to Prescribing Opioids for Chronic Pain